Now that all the key deadlines for Obamacare have finally taken effect, a lot of tech investors are busy trying to figure out how this will affect their portfolios.
It's easy to see why. This is the largest and most fundamental change to hit the healthcare sector in decades.
Not only that, but Wall Street is currently trying to pick the winners from the losers - and frankly isn't doing a particularly good job of it.
Fact is, Obamacare is at least partly responsible for some of the biotech sector's recent sell-off... Full Story